These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9446746)

  • 21. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-induced domain movement in an antibody Fab: molecular dynamics studies confirm the unique domain movement observed experimentally for Fab NC6.8 upon complexation and reveal its segmental flexibility.
    Sotriffer CA; Liedl KR; Linthicum DS; Rode BM; Varga JM
    J Mol Biol; 1998 May; 278(2):301-6. PubMed ID: 9571052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergency step-by-step specific immunotherapy in severe digoxin poisoning: an observational cohort study.
    Bilbault P; Oubaassine R; Rahmani H; Lavaux T; Castelain V; Sauder P; Schneider F
    Eur J Emerg Med; 2009 Jun; 16(3):145-9. PubMed ID: 19262393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of ligand binding by bioaffinity mass spectrometry.
    Zhu Y; Valdes R; Simmons CQ; Linder MW; Pugia MJ; Jortani SA
    Clin Chim Acta; 2006 Sep; 371(1-2):71-8. PubMed ID: 16624266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
    Pullen MA; Brooks DP; Edwards RM
    J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
    Domart Y; Bismuth C; Schermann JM; Abuaf N; Pontal PG; Baud F; Bolo A; Gailliot M; Fournier PE
    Nouv Presse Med; 1982 Dec; 11(52):3827-30. PubMed ID: 7162976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of surface plasmon resonance toward studies of low-molecular-weight antigen-antibody binding interactions.
    Adamczyk M; Moore JA; Yu Z
    Methods; 2000 Mar; 20(3):319-28. PubMed ID: 10694454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of human single-chain variable fragment (scFv) antibody specific for digoxin by ribosome display.
    Yan XH; Xu ZR
    Indian J Biochem Biophys; 2005 Dec; 42(6):350-7. PubMed ID: 16955735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of specificity in an immune network.
    Harada K; Ikegami T
    J Theor Biol; 2000 Apr; 203(4):439-49. PubMed ID: 10736219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies that distinguish between two related digitalis glycosides, ouabain and digoxin.
    Parhami-Seren B; Bell C; Margolies MN; Haupert GT
    J Immunol; 1999 Oct; 163(8):4360-6. PubMed ID: 10510376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of human monoclonal antibodies to digoxin.
    Ball WJ; Kasturi R; Dey P; Tabet M; O'Donnell S; Hudson D; Fishwild D
    J Immunol; 1999 Aug; 163(4):2291-8. PubMed ID: 10438974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational changes in the antibody constant domains upon hapten-binding.
    Sagawa T; Oda M; Morii H; Takizawa H; Kozono H; Azuma T
    Mol Immunol; 2005 Jan; 42(1):9-18. PubMed ID: 15488939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of a peptide from the receptor-binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: changes in backbone dynamics induced by binding.
    Campbell AP; Spyracopoulos L; Wong WY; Irvin RT; Sykes BD
    Biochemistry; 2003 Sep; 42(38):11334-46. PubMed ID: 14503884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific antibody-DNA interaction: a novel strategy for tight DNA recognition.
    Di Pietro SM; Centeno JM; Cerutti ML; Lodeiro MF; Ferreiro DU; Alonso LG; Schwarz FP; Goldbaum FA; de Prat-Gay G
    Biochemistry; 2003 May; 42(20):6218-27. PubMed ID: 12755625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
    Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
    Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.
    Graff CP; Wittrup KD
    Cancer Res; 2003 Mar; 63(6):1288-96. PubMed ID: 12649189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.